B Ellenbroek
B Ellenbroek
Verified email at vuw.ac.nz
TitleCited byYear
Early maternal deprivation reduces the expression of BDNF and NMDA receptor subunits in rat hippocampus
M Roceri, W Hendriks, G Racagni, BA Ellenbroek, MA Riva
Molecular psychiatry 7 (6), 609, 2002
4372002
Search after neurobiological profile of individual-specific features of Wistar rats
AR Cools, R Brachten, D Heeren, A Willemen, B Ellenbroek
Brain research bulletin 24 (1), 49-69, 1990
2911990
The effects of an early stressful life event on sensorimotor gating in adult rats
BA Ellenbroek, PTJM van den Kroonenberg, AR Cools
Schizophrenia research 30 (3), 251-260, 1998
2581998
Animal models with construct validity for schizophrenia.
BA Ellenbroek, AR Cools
Behavioural Pharmacology, 1990
2581990
Animal behavior models of the mechanisms underlying antipsychotic atypicality
MA Geyer, B Ellenbroek
Progress in Neuro-Psychopharmacology and Biological Psychiatry 27 (7), 1071-1079, 2003
2382003
Characterization of the serotonin transporter knockout rat: a selective change in the functioning of the serotonergic system
JR Homberg, JDA Olivier, BMG Smits, JD Mul, J Mudde, M Verheul, ...
Neuroscience 146 (4), 1662-1676, 2007
2022007
Prepulse inhibition and latent inhibition: the role of dopamine in the medial prefrontal cortex
BA Ellenbroek, S Budde, AR Cools
Neuroscience 75 (2), 535-542, 1996
1991996
Animal models for the negative symptoms of schizophrenia
BA Ellenbroek, AR Cools
Behavioural pharmacology 11 (3 & 4), 223-233, 2000
1922000
A study in male and female 5-HT transporter knockout rats: an animal model for anxiety and depression disorders
JDA Olivier, MGC Van Der Hart, RPL Van Swelm, PJ Dederen, ...
Neuroscience 152 (3), 573-584, 2008
1862008
Generation of gene knockouts and mutant models in the laboratory rat by ENU-driven target-selected mutagenesis
BMG Smits, JB Mudde, J van de Belt, M Verheul, J Olivier, J Homberg, ...
Pharmacogenetics and genomics 16 (3), 159-169, 2006
1692006
The histamine H3 receptor as a therapeutic drug target for CNS disorders
MJ Gemkow, AJ Davenport, S Harich, BA Ellenbroek, A Cesura, D Hallett
Drug discovery today 14 (9-10), 509-515, 2009
1552009
Treatment of schizophrenia: a clinical and preclinical evaluation of neuroleptic drugs
BA Ellenbroek
Pharmacology & therapeutics 57 (1), 1-78, 1993
1531993
Role of cannabis and endocannabinoids in the genesis of schizophrenia
E Fernandez-Espejo, MP Viveros, L Nez, BA Ellenbroek, ...
Psychopharmacology 206 (4), 531-549, 2009
1462009
The behavior of APO-SUS rats in animal models with construct validity for schizophrenia
BA Ellenbroek, MA Geyer, AR Cools
Journal of Neuroscience 15 (11), 7604-7611, 1995
1371995
Early maternal deprivation and prepulse inhibition: the role of the postdeprivation environment
BA Ellenbroek, AR Cools
Pharmacology Biochemistry and Behavior 73 (1), 177-184, 2002
1202002
Apomorphine susceptibility and animal models for psychopathology: genes and environment
BA Ellenbroek, AR Cools
Behavior genetics 32 (5), 349-361, 2002
1172002
The long-term effects of maternal deprivation depend on the genetic background
BA Ellenbroek, AR Cools
Neuropsychopharmacology 23 (1), 99, 2000
1152000
Structural and behavioural consequences of double deficiency for creatine kinases BCK and UbCKmit
F Streijger, F Oerlemans, BA Ellenbroek, CR Jost, B Wieringa, ...
Behavioural brain research 157 (2), 219-234, 2005
1092005
Rodent models in neuroscience research: is it a rat race?
B Ellenbroek, J Youn
Disease models & mechanisms 9 (10), 1079-1087, 2016
1042016
Gating function of noradrenaline in the ventral striatum: Its role in behavioural responses to environmental and pharmacological challenges
AR Cools
The mesolimbic dopamine system: From motivation to action, 141-173, 1991
1001991
The system can't perform the operation now. Try again later.
Articles 1–20